期刊文献+

我院2型糖尿病患者阿司匹林的应用情况调查 被引量:2

Utilization of Aspirin in Patients with Type 2 Diabetes Mellitus
原文传递
导出
摘要 目的:调查2型糖尿病患者应用阿司匹林的情况。方法:对我院2004年4月~2007年4月内分泌科510例2型糖尿病住院患者阿司匹林的应用情况进行回顾性分析。结果:我院内分泌科2型糖尿病住院患者阿司匹林的应用率为68.2%,日剂量达50~100mg,合并冠心病、高血压者阿司匹林应用率较高(P<0.05)。结论:我院2型糖尿病患者阿司匹林应用率较高,在应用年龄及应用剂量上应加强规范化管理。 OBJECTIVE: To investigate the utilization of aspirin in patients with type 2 diabetes mellitus. METHODS: The utilization of aspirin in 510 inpatients with type 2 diabetes mellitus in the department of Endocrinology in our hospital from April 2004 to April 2007 was analyzed retrospectively. RESULTS: Of the total 510 cases, 68.2% received aspirin, with daily dose reached 50--100mg. Aspirin was more often used in patients complicated with coronary heart disease and hypertension(P〈0.05). CONCLUSION: The proportion of patients who received aspirin in our hospital is on the high side, therefore, standardized management on the application age and dose of aspirin should be strengthened.
出处 《中国药房》 CAS CSCD 北大核心 2008年第23期1774-1776,共3页 China Pharmacy
关键词 阿司匹林 2型糖尿病 心血管疾病 美国糖尿病学会指南 Aspirin Type 2 diabetes mellitus Cardiovascular disease American Diabetes Association Guidelines
  • 相关文献

参考文献10

  • 1Halushka PV, Rogers RC, Loadholt CB,et al. Increased platelet thromboxane synthesis in diabetes mellitus[J ] .J Lab Clin Med , 1981,97(1) : 87.
  • 2Davi G, Catalano I, Averna M, et al .Thromboxane biosynthesis and platelet function in type Ⅱ diabetes mellitus[J ] .N Engl J ivied, 1990,322(25) : 1 769.
  • 3Leitao CB, Krahe AL, Nabinger GB, et al .Aspirin therapy is still underutilized among patients with type 2 diabe tes[J] . Arq Bras Endocrinol Metabol , 2006, 50(6): 1 014.
  • 4Stamler J, Vaccaro O, Neaton JD, et al .Diabetes, other risk factors, and 12 - yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial [J ]. Diabetes Care, 1993,16(2) :434.
  • 5Colwell JA.Aspirin therapy in diabetes[J] . Diabetes Care, 1997, 20(11) : 1 767.
  • 6American Diabetes Association. Aspirin therapy in diabetes[J ]. Diabetes Care, 2000,23(Suppl 1) : 61.
  • 7Colwell JA, American Diabetes Association. Aspirin therapy in diabetes [J ]. Did Seres Care, 2003,26(1) : 87.
  • 8Colwell JA, American Diabetes Association. Aspirin therapy in diabetes[ J ]. Diabetes Care, 2004, 27(1) : 72.
  • 9Collaborative overview of randomised trials of antiplatelet therapy I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration [J ]. BMJ, 1994,308( 6 921) : 81.
  • 10Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group[J]. N Engl J Med, 1989,321(3) : 129.

同被引文献13

  • 1李立明,饶克勤,孔灵芝,姚崇华,向红丁,翟凤英,马冠生,杨晓光,中国居民营养与健康状况调查技术执行组.中国居民2002年营养与健康状况调查[J].中华流行病学杂志,2005,26(7):478-484. 被引量:1783
  • 2Wenying Yang,Juming Lu,Jianping Weng,et al.Prevalence of Diabetes among Men and Women in China.N Engl J Med 2010,362:1090-1101.
  • 3He J,Gu D,Wu X,et al.Major causes of death among men and women in China.N Engl J Med 2005,353:1124-1134.
  • 4World Health Organization.Definition,Diagnosis and Classification of Diabetes Mellitus and its Complications.In:Report of a WHO Consultation.WHO/NCD/NCS/99.2.Geneva:WHO,1999.
  • 5Kanaya AM,Grady D,Barrett-Connor E.Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus:a meta-analysis.Arch Intern Med,2002,162:1737-1745.
  • 6Ogawa H,Nakayama M,Morimoto T,et al.Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes:a randomized controlled trial.JAMA,2008,300(18):2134-2141.
  • 7Hayden M,Pignone M,Phillips C,et al.Aspirin for the primary prevention of cardiovascular events:a summary of the evidence for the U.S.Preventive Services Task Force.Ann Intern Med,2002,136:161-172.
  • 8罗婉莹,唐福明,吴筠,刘凯,谢芳英,蔡德鸿.社区医院糖尿病患者阿司匹林使用情况[J].实用医学杂志,2008,24(1):126-129. 被引量:8
  • 9中国2型糖尿病防治指南(2007年版)[J].中华医学杂志,2008,88(18):1227-1245. 被引量:954
  • 10顾刘宝,卞茸文,夏晖,解雨春,娄青林,欧阳晓俊.阿司匹林对2型糖尿病患者血清可溶性CD40配体水平的影响[J].中国糖尿病杂志,2008,16(5):285-287. 被引量:6

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部